October 14, 2019
German pharma giant Bayer has announced this month that it will be working with 11 additional startups to accelerate the development of digital products improving patients’ health through its G4A Digital Health Partnerships programme.
The startups, which look at oncology, cardiovascular diseases and others, were selected from over 750 applications spanning 65 countries based on the development...
August 6, 2019
Paris, France-based Voluntis has received FDA marketing authorization for an algorithm-driven digital tool that helps cancer patients manage their symptoms and care teams identify clinical insights, the company announced last week.
The Oleena software is a Class II medical device that is prescribed by the patient’s care team. As the user logs their symptoms into the app, it adapts to offer...
July 24, 2019
Malmö-based medical device startup Flow has landed $1.5m (approximately €1.35m) in funding in a round led by Khosla Ventures, it was announced this week. The new funds will be used to support the European rollout of Flow's brain stimulation headset and therapy app, developed to treat depression, which were launched in the UK and Sweden earlier this year.
“The Khosla Ventures investment will...
May 23, 2019
It is well-known that there are some situations in which physicians continue to resist the use of mobile health solutions, and a recent study published in JMIR at the beginning of May sought to identify some of the factors that play a key role in the adoption of a free oncology decision support app.
Oncology is a growing space in digital health. CE-approved ONCOassist, launched in 2012, gives...
Inside the wearable device, the blood pump sits in the upper left corner while the heparin injector runs the length of the near side of the box. The green circuit boards control the blood pump, heparin injector and provide display data. Photo Credit: Tae Hyun Kim
April 1, 2019
In an open Nature Communications paper published today, researchers from the University of Michigan described a prototype wearable device that could continuously collect bloodborne cancer cells often used as a biomarker for treatment.
Currently, blood draws are required to identify and examine circulating tumor cells (CTCs), and are often limited by inconsistent CTC counts as well as the health...
Above: Screengrab of Burning Rock's website.
February 14, 2019
Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C financing totaling RMB 850 million. The financing was led by GIC, followed by LYFE Capital, CMB International Capital, Lilly Asia Ventures (LAV), Sequoia Capital China and T&Brothers Capital. The...
Photo credit: Oncology Analytics
November 8, 2018
Earlier this week Oncology Analytics, a technology company focused on helping organizations apply and manage benefits for cancer care, announced that it closed a $21 million Series B funding round. The new round was led by Oak HC/FT with participation from McKesson Ventures, Blue Cross Blue Shield Venture Partners and Sandbox Advantage.
The company said the new money will help it expand its...
March 2, 2018
Artificial intelligence has been working its way into the field of research. Now Precision Health AI, a company that specializes in applications of AI to oncology, has just launched a new platform, called Eureka Health Oncology, that uses EMR data to provide practical AI applications for real oncology use cases.
“Our team of healthcare professionals is using the deep clinical oncology dataset at...
February 15, 2018
Pharma giant Roche is set to acquire oncology EHR software firm Flatiron Health in the first half of 2018, the companies announced today in a statement. Roche will pay an additional $1.9 billion over the millions it had already invested into the company in 2016, and as a result of the deal will control all shares of Flatiron Health.
“This is an important step in our personalized healthcare...
October 18, 2017
Two years after launching its smoking cessation app Quitter's Circle, pharmaceutical company Pfizer is seeing impressive continued engagement with the app. It's also applying the lessons learned from Quitter's Circle toward other mobile health pursuits — including a recently-launched app for people living with cancer.
"We can do surveys right in the app," Mark Pizzini, Pfizer's digital strategy...